.Merck beats incomes assumptions, increases purchases outlook on powerful demand for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Revenue Estimates as Keytruda Sales Rise BloombergMerck Inventory: Pharma Giant Posts Solid End Results, But Expectation Drops Short Client's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck trumps revenue and also sales desires among Keytruda strength, yet delivers combined full-year outlook MarketWatch.